1. Home
  2. TRVI vs MSB Comparison

TRVI vs MSB Comparison

Compare TRVI & MSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • MSB
  • Stock Information
  • Founded
  • TRVI 2011
  • MSB 1961
  • Country
  • TRVI United States
  • MSB United States
  • Employees
  • TRVI N/A
  • MSB N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • MSB Metal Mining
  • Sector
  • TRVI Health Care
  • MSB Basic Materials
  • Exchange
  • TRVI Nasdaq
  • MSB Nasdaq
  • Market Cap
  • TRVI 341.4M
  • MSB 379.4M
  • IPO Year
  • TRVI 2019
  • MSB N/A
  • Fundamental
  • Price
  • TRVI $4.24
  • MSB $24.81
  • Analyst Decision
  • TRVI Strong Buy
  • MSB
  • Analyst Count
  • TRVI 8
  • MSB 0
  • Target Price
  • TRVI $9.31
  • MSB N/A
  • AVG Volume (30 Days)
  • TRVI 454.6K
  • MSB 122.2K
  • Earning Date
  • TRVI 03-19-2025
  • MSB 01-01-0001
  • Dividend Yield
  • TRVI N/A
  • MSB 28.02%
  • EPS Growth
  • TRVI N/A
  • MSB 714.88
  • EPS
  • TRVI N/A
  • MSB 7.00
  • Revenue
  • TRVI N/A
  • MSB $26,785,162.00
  • Revenue This Year
  • TRVI N/A
  • MSB N/A
  • Revenue Next Year
  • TRVI N/A
  • MSB N/A
  • P/E Ratio
  • TRVI N/A
  • MSB $3.45
  • Revenue Growth
  • TRVI N/A
  • MSB 85.21
  • 52 Week Low
  • TRVI $1.39
  • MSB $15.93
  • 52 Week High
  • TRVI $4.68
  • MSB $37.00
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 60.00
  • MSB 39.18
  • Support Level
  • TRVI $3.81
  • MSB $23.06
  • Resistance Level
  • TRVI $4.04
  • MSB $37.00
  • Average True Range (ATR)
  • TRVI 0.25
  • MSB 2.01
  • MACD
  • TRVI -0.00
  • MSB -0.79
  • Stochastic Oscillator
  • TRVI 90.89
  • MSB 12.55

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About MSB Mesabi Trust

Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of the assets held. The company's principally wholly-owned segment is the iron ore mining segment and it generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.

Share on Social Networks: